US Patent 11525137 Compositions and methods of treating Facioscapulohumeral muscular dystrophy
Patent 11525137 was granted and assigned to Avidity Biosciences on December, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 2 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 Jul, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 6 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 2 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Barbora Malecova0
Beatrice Diana Darimont0
David Sala Cano0
Rob Burke0
Edits on 27 Apr, 2023
Golden AI
Infobox
Edits on 23 Apr, 2023
Golden AI
Infobox
Edits on 1 Apr, 2023
Golden AI
Infobox
Edits on 14 Dec, 2022
Golden AI
Edits made to:
Infobox (+17 properties)
Article (+142 characters)
US Patent 11525137 Compositions and methods of treating Facioscapulohumeral muscular dystrophy
Article
Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating Facioscapulohumeral muscular dystrophy.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115251370
Date of Patent
December 13, 2022
0Patent Application Number
172006610
Date Filed
March 12, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11525137 Compositions and methods of treating Facioscapulohumeral muscular dystrophy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.